Switch to:
More From Other Websites
Nasdaq stocks posting largest volume increases Aug 28 2014
CAS MEDICAL SYSTEMS INC Financials Aug 19 2014
August 06 CASMED Annonces Second Quarter 2014 Financial Results Aug 06 2014
CAS MEDICAL SYSTEMS INC Files SEC form 8-K, Results of Operations and Financial Condition Aug 06 2014
Q2 2014 CAS Medical Systems Inc Earnings Release - Before Market Open Aug 06 2014
CASMED Announces Second Quarter 2014 Financial Results Aug 06 2014
CASMED to Announce Second Quarter 2014 Financial Results and Hold Conference Call on August 6th Jul 29 2014
CAS MEDICAL SYSTEMS INC Files SEC form 8-K, Other Events Jul 02 2014
CAS MEDICAL SYSTEMS INC Files SEC form 8-K, Creation of a Direct Financial Obligation or an... Jun 30 2014
CASMED Secures $10 Million Loan Agreement with GE Capital Healthcare Financial Services Jun 30 2014
CAS MEDICAL SYSTEMS INC Files SEC form 8-K, Change in Directors or Principal Officers, Submission of... Jun 27 2014
CAS Medical cleared to market Fore-Sight Elite Oximeters in Japan Jun 26 2014
CASMED Receives Regulatory Clearance to Market FORE-SIGHT ELITE(R) Oximeters in Japan Jun 26 2014
CASMED and Century Medical Execute Distribution Agreement for FORE-SIGHT(R) Oximeters in Japan May 29 2014
CAS Medical receives FDA approval for Fore-Sight Elite in non-cerebral tissue May 07 2014
CAS MEDICAL SYSTEMS INC Files SEC form 10-Q, Quarterly Report May 02 2014
CAS MEDICAL SYSTEMS INC Files SEC form 8-K, Results of Operations and Financial Condition May 01 2014
March 20 CASMED Places 1,000th FORE-SIGHT® Cerebral Oximeter Mar 20 2014
CAS MEDICAL SYSTEMS INC Files SEC form 10-K, Annual Report Mar 19 2014
March 18 CASMED Names Karen Harris-Coleman Executive Vice President, International Sales Mar 18 2014

Add Notes, Comments or Ask Questions

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK